User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 5 results.
    • Journal article
    Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.
    Chanan-Khan, Asher Cramer, Paula Demirkan, Fatih Fraser, Graeme Silva, Rodrigo Santucci Grosicki, Sebastian Pristupa, Aleksander Janssens, Ann Mayer, Jiri Bartlett, Nancy L Dilhuydy, Marie-Sarah Pylypenko, Halyna Loscertales, Javier Avigdor, Abraham Rule, Simon Villa, Diego Samoilova, Olga Panagiotidis, Panagiots Goy, Andre Mato, Anthony HELIOS investigators Van Den Neste, Eric[UCL] (2016) The Lancet Oncology — Vol. 17, no. 2, p. 200-211 (2016)
    • Journal article
    Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study.
    Schuster, Michael Zijlstra, Josée Casasnovas, Rene-Olivier Vermaat, Joost S P Kalakonda, Nagesh Goy, Andre Choquet, Sylvain Neste, Eric Van Den[UCL] Hill, Brian Thieblemont, Catherine Cavallo, Federica De la Cruz, Fatima Kuruvilla, John Hamad, Nada Jaeger, Ulrich Caimi, Paolo Gurion, Ronit Warzocha, Krzysztof Bakhshi, Sameer Sancho, Juan-Manuel Follows, George Egyed, Miklos Offner, Fritz Vassilakopoulos, Theodoros Samal, Priyanka Ku, Matthew Ma, Xiwen Corona, Kelly Chamoun, Kamal Shah, Jatin Shacham, Sharon Kauffman, Michael G Canales, Miguel Maerevoet, Marie (2022) Clinical lymphoma, myeloma & leukemia — Vol. 22, no.7, p. 483-494 (2022)
    • Journal article
    Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial.
    Kalakonda, Nagesh Maerevoet, Marie Cavallo, Federica Follows, George Goy, Andre Vermaat, Joost S P Casasnovas, Olivier Hamad, Nada Zijlstra, Josée M Bakhshi, Sameer Bouabdallah, Reda Choquet, Sylvain Gurion, Ronit Hill, Brian Jaeger, Ulrich Sancho, Juan Manuel Schuster, Michael Thieblemont, Catherine De la Cruz, Fátima Egyed, Miklos Mishra, Sourav Offner, Fritz Vassilakopoulos, Theodoros P Warzocha, Krzysztof McCarthy, Daniel Ma, Xiwen Corona, Kelly Saint-Martin, Jean-Richard Chang, Hua Landesman, Yosef Joshi, Anita Wang, Hongwei Shah, Jatin Shacham, Sharon Kauffman, Michael Van Den Neste, Eric[UCL] Canales, Miguel A (2020) The Lancet. Haematology — Vol. 7, no.7, p. e511-e522 (2020)
    • Journal article
    Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study
    Maerevoet, Marie Zijlstra, Josee M. Follows, George Casasnovas, Rene-Olivier Vermaat, J. S. P. Kalakonda, Nagesh Goy, Andre Choquet, Sylvain Van Den Neste, Eric[UCL] Hill, Brian Thieblemont, Catherine Cavallo, Federica De la Cruz, Fatima Kuruvilla, John Hamad, Nada Jaeger, Ulrich Caimi, Paolo Gurion, Ronit Warzocha, Krzysztof Bakhshi, Sameer Sancho, Juan-Manuel Schuster, Michael Egyed, Miklos Offner, Fritz Vassilakopoulos, Theodoros P. Samal, Priyanka Ku, Matthew Ma, Xiwen Corona, Kelly Chamoun, Kamal Shah, Jatin Shacham, Sharon Kauffman, Michael G. Canales, Miguel (2021) Journal of Hematology & Oncology — Vol. 14, no.1, p. 1-4 (2021)
    • Journal article
    Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes.
    Casasnovas, Rene-Olivier Follows, George Zijlstra, Josee M Vermaat, Joost S P Kalakonda, Nagesh Choquet, Sylvain Neste, Eric Van Den[UCL] Hill, Brian Thieblemont, Catherine Cavallo, Federica la Cruz, Fatima De Kuruvilla, John Hamad, Nada Jaeger, Ulrich Caimi, Paolo F Gurion, Ronit Warzocha, Krzysztof Bakhshi, Sameer Sancho, Juan-Manuel Schuster, Michael Egyed, Miklos Offner, Fritz Vassilakopoulos, Theodoros P Samal, Priyanka Ku, Matthew Ma, Xiwen Chamoun, Kamal Shah, Jatin Canales, Miguel Maerevoet, Marie Shacham, Sharon Kauffman, Michael G Goy, Andre (2022) Clinical lymphoma, myeloma & leukemia — Vol. 22, no.1, p. 24-33 (2022)